Rachelle S. Doody, M.D., Ph.D.

Professor of Neurology
Effie Marie Cain Chair in Alzheimer's Disease Research

Clinical Service Area

Neurology

Specialty

Alzheimer's Disease
Memory Disorders

Board Certification

American Board of Psychiatry and Neurology, Neurology

Clinic Appointments

713-798-4734

Consult

713-798-4734

Medical School

Baylor College of Medicine, Houston, TX

Internship

Internal Medicine, McGill University Faculty of Medicine, Montreal, Quebec , Canada

Residency

Neurology, Baylor College of Medicine, Houston, TX

Clinical Interests

Alzheimer's disease, neurodegenerative dementias, Ischernic Vascular Dementia, memory loss, mild cognitive impairment

Clinic Location

Baylor Neurology
Smith Tower
6550 Fannin, Suite 1801
Houston, TX 77030

Research Interests

Cognitive aspects of Alzheimer's disease, dementia, and aphasia. Alzheimer's Disease therapeutics and modeling of progression for clinical prognostication, validation of biological markers, and enhancing design of AD clinical trials.

Publications

Doody RS, Corey-Bloom J, Zhang R, Li H, Ieni J, Schindler R. Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease. Drugs Aging 2008;25:163-74.
Yan JH, Rountree S, Massman P, Doody RS, Li H. Alzheimer's disease and mild cognitive impairment deteriorate fine movement control. J Psychiatr Res 2008;:.
Atchison TB, Massman PJ, Doody RS. Baseline cognitive function predicts rate of decline in basic-care abilities of individuals with dementia of the Alzheimer's type. Arch Clin Neuropsychol 2007;22:99-107.
Black SE, Doody R, Li H, McRae T, Jambor KM, Xu Y, Sun Y, Perdomo CA, Richardson S. Donepezil preserves cognition and global function in patients with severe Alzheimer disease. Neurology 2007;69:459-69.
Cummings JL, Doody R, Clark C. Disease-modifying therapies for Alzheimer disease: challenges to early intervention. Neurology 2007;69:1622-34.
Jack CR, Jr., Petersen RC, Grundman M, Jin S, Gamst A, Ward CP, Sencakova D, Doody RS, Thal LJ. Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI. Neurobiol Aging 2007;:.
Park KW, Pavlik VN, Rountree SD, Darby EJ, Doody RS. Is functional decline necessary for a diagnosis of Alzheimer's disease?. Dement Geriatr Cogn Disord 2007;24:375-9.
Rountree SD, Waring SC, Chan WC, Lupo PJ, Darby EJ, Doody RS. Importance of subtle amnestic and nonamnestic deficits in mild cognitive impairment: prognosis and conversion to dementia. Dement Geriatr Cogn Disord 2007;24:476-82.
Dyer CB, Kelly PA, Pavlik VN, Lee J, Doody RS, Regev T, Pickens S, Burnett J, Smith SM. The making of a self-neglect severity scale. J Elder Abuse Negl 2006;18:13-23.
Fillit HM, Doody RS, Binaso K, Crooks GM, Ferris SH, Farlow MR, Leifer B, Mills C, Minkoff N, Orland B, Reichman WE, Salloway S. Recommendations for best practices in the treatment of Alzheimer's disease in managed care. Am J Geriatr Pharmacother 2006;:S9-S24; quiz S25-S28.
Geldmacher DS, Frolich L, Doody RS, Erkinjuntti T, Vellas B, Jones RW, Banerjee S, Lin P, Sano M. Realistic expectations for treatment success in Alzheimer's disease. J Nutr Health Aging 2006;10:417-29.
Pavlik VN, Doody RS, Massman PJ, Chan W. Influence of premorbid IQ and education on progression of Alzheimer's disease. Dement Geriatr Cogn Disord 2006;22:367-77.
Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ. A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease. Arch Neurol 2006;63:49-54.
Schneider LS, Clark CM, Doody R, Ferris SH, Morris JC, Raman R, Reisberg B, Schmitt FA. ADCS Prevention Instrument Project: ADCS-clinicians' global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions. Alzheimer Dis Assoc Disord 2006;20:S124-38.
Doody R, Pavlik V, Massman P, Kenan M, Yeh S, Powell S, Cooke N, Dyer C, Demirovic J, Waring S, Chan W. Changing patient characteristics and survival experience in an Alzheimer's center patient cohort. Dement Geriatr Cogn Disord 2005;20:198-208.
Doody RS. Refining treatment guidelines in Alzheimer's disease. Geriatrics 2005;:14-20.
Graham DP, Kunik ME, Doody R, Snow AL. Self-reported awareness of performance in dementia. Brain Res Cogn Brain Res 2005;25:144-52.
Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease. Arch Neurol 2005;62:454-9.
Pavlik VN, Hyman DJ, Doody R. Cardiovascular risk factors and cognitive function in adults 30-59 years of age (NHANES III). Neuroepidemiology 2005;24:42-50.
Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005;352:2379-88.
Roman GC, Wilkinson DG, Doody RS, Black SE, Salloway SP, Schindler RJ. Donepezil in vascular dementia: combined analysis of two large-scale clinical trials. Dement Geriatr Cogn Disord 2005;20:338-44.
Snow AL, Graham DP, Molinari VA, Orengo CA, Doody RS, Norris MP, Kunik ME. Factors affecting deficit awareness in persons with dementia. Dement Geriatr Cogn Disord 2005;20:133-9.
Snow AL, Kunik ME, Molinari VA, Orengo CA, Doody R, Graham DP, Norris MP. Accuracy of self-reported depression in persons with dementia. J Am Geriatr Soc 2005;53:389-96.
Waring SC, Doody RS, Pavlik VN, Massman PJ, Chan W. Survival among patients with dementia from a large multi-ethnic population. Alzheimer Dis Assoc Disord 2005;19:178-83.
Doody R, Wirth Y, Schmitt F, Mobius HJ. Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer's disease. Dement Geriatr Cogn Disord 2004;18:227-32.
Doody RS, Dunn JK, Huang E, Azher S, Kataki M. A method for estimating duration of illness in Alzheimer's disease. Dement Geriatr Cogn Disord 2004;17:04-Jan.
Graham DP, Cully JA, Snow AL, Massman P, Doody R. The Alzheimer's Disease Assessment Scale-Cognitive subscale: normative data for older adult controls. Alzheimer Dis Assoc Disord 2004;18:236-40.
Grundman M, Petersen RC, Ferris SH, Thomas RG, Aisen PS, Bennett DA, Foster NL, Jack CR, Jr., Galasko DR, Doody R, Kaye J, Sano M, Mohs R, Gauthier S, Kim HT, Jin S, Schultz AN, Schafer K, Mulnard R, van Dyck CH, et al.. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 2004;61:59-66.
Snow AL, Norris MP, Doody R, Molinari VA, Orengo CA, Kunik ME. Dementia Deficits Scale. Rating self-awareness of deficits. Alzheimer Dis Assoc Disord 2004;18:22-31.
Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D, Morris JC, McKeel DW, Jr., Farlow M, Weitlauf SL, Quinn J, Kaye J, Knopman D, Arai H, Doody RS, DeCarli C, Leight S, Lee VM, Trojanowski JQ. Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?. Arch Neurol 2003;60:1696-702.
Davis RN, Massman PJ, Doody RS. WAIS-R factor structure in Alzheimer's disease patients: a comparison of alternative models and an assessment of their generalizability. Psychol Aging 2003;18:836-43.
Davis RN, Massman PJ, Doody RS. Effects of blood pressure on neuropsychological functioning in Alzheimer's disease. Arch Clin Neuropsychol 2003;18:19-32.
Doody RS. Current treatments for Alzheimer's disease: cholinesterase inhibitors. J Clin Psychiatry 2003;:07-Nov.
Reisberg B, Doody R, Stoffler A, Schmitt F, Ferris S, Mobius HJ. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med 2003;348:1333-41.
Wilkinson D, Doody R, Helme R, Taubman K, Mintzer J, Kertesz A, Pratt RD. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology 2003;61:479-86.
Quinn J, Moore M, Benson DF, Clark CM, Doody R, Jagust W, Knopman D, Kaye JA. A videotaped CIBIC for dementia patients: validity and reliability in a simulated clinical trial. Neurology 2002;58:433-7.
Weiner MF, Doody RS, Sairam R, Foster B, Liao TY. Prevalence and incidence of major depressive disorder in Alzheimer's disease: findings from two databases. Dement Geriatr Cogn Disord 2002;13:12-Aug.
Davis RN, Massman PJ, Doody RS. Cognitive intervention in Alzheimer disease: a randomized placebo-controlled study. Alzheimer Dis Assoc Disord 2001;15:09-Jan.
Doody RS, Dunn JK, Clark CM, Farlow M, Foster NL, Liao T, Gonzales N, Lai E, Massman P. Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease. Dement Geriatr Cogn Disord 2001;12:295-300.
Doody RS, Geldmacher DS, Gordon B, Perdomo CA, Pratt RD. Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. Arch Neurol 2001;58:427-33.
Doody RS, Massman P, Dunn JK. A method for estimating progression rates in Alzheimer disease. Arch Neurol 2001;58:449-54.
Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1154-66.
Mohs RC, Doody RS, Morris JC, Ieni JR, Rogers SL, Perdomo CA, Pratt RD. A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology 2001;57:481-8.
Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-92.
Tangalos E, Doody R, Tariot P. Alzheimer's disease in long-term care: maximizing treatment options. J Am Med Dir Assoc 2001;2:H17-20.
Doody RS. The issue of representation in brain research. Brain Cogn 2000;42:26-8.
Doody RS. Mortality from pneumonia and hip fractures in patients with advanced dementia. Jama 2000;284:2447; author reply 2448.
Doody RS, Azher SN, Haykal HA, Dunn JK, Liao T, Schneider L. Does APO epsilon4 correlate with MRI changes in Alzheimer's disease?. J Neurol Neurosurg Psychiatry 2000;69:668-71.
Hanna PA, Doody RS. Alien limb sign. Adv Neurol 2000;82:135-45.
Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ. Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. Jama 2000;283:1007-15.
Rogers SL, Doody RS, Pratt RD, Ieni JR. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study. Eur Neuropsychopharmacol 2000;10:195-203.
Doody RS. Therapeutic standards in Alzheimer disease. Alzheimer Dis Assoc Disord 1999;:S20-6.
Doody RS. Clinical profile of donepezil in the treatment of Alzheimer's disease. Gerontology 1999;:23-32.
Doody RS. Clinical benefits of a new piperidine-class AChE inhibitor. Eur Neuropsychopharmacol 1999;:S69-77.
Doody RS, Strehlow SL, Massman PJ, Feher EP, Clark C, Roy JR. Baylor profound mental status examination: a brief staging measure for profoundly demented Alzheimer disease patients. Alzheimer Dis Assoc Disord 1999;13:53-9.
Doody RS, Vacca JL, Massman PJ, Liao TY. The influence of handedness on the clinical presentation and neuropsychology of Alzheimer disease. Arch Neurol 1999;56:1133-7.
Doody R, Whitehouse PJ, Chen Q, Wang L, Wu Q, Rosser M, Xu XH. Alzheimer disease-related activities in China: a report from the International Working Group on the Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord 1998;12:263-5.
Rogers SL, Doody RS, Mohs RC, Friedhoff LT. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med 1998;158:1021-31.
Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology 1998;50:136-45.
Amaducci L, Baldereschi M, Doody R, Chandra V, Gaines AD. Cultural issues in the clinical diagnosis of Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord 1997;:19-21.
Antuono P, Doody R, Gilman S, Huff J, Scheltens P, Ueda K, Khachaturian ZS. Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord 1997;:22-5.
Clark CM, Ewbank D, Lerner A, Doody R, Henderson VW, Panisset M, Morris JC, Fillenbaum GG, Heyman A. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease. Neurology 1997;49:70-5.
Perkins P, Annegers JF, Doody RS, Cooke N, Aday L, Vernon SW. Incidence and prevalence of dementia in a multiethnic cohort of municipal retirees. Neurology 1997;49:44-50.
Reisberg B, Schneider L, Doody R, Anand R, Feldman H, Haraguchi H, Kumar R, Lucca U, Mangone CA, Mohr E, Morris JC, Rogers S, Sawada T. Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord 1997;:18-Aug.
Sabbagh MN, Lynn P, Jhingran S, Massman P, Villanueva-Meyer J, Olup J, Doody RS. Correlations between SPECT regional cerebral blood flow and psychometric testing in patients with Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1997;9:68-74.
Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, Schmitt FA, Grundman M, Thomas RG, Ferris SH. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997;:S22-32.
Strite D, Massman PJ, Cooke N, Doody RS. Neuropsychological asymmetry in Alzheimer's disease: verbal versus visuoconstructional deficits across stages of dementia. J Int Neuropsychol Soc 1997;3:420-7.
Thal LJ, Carta A, Doody R, Leber P, Mohs R, Schneider L, Shimohama S, Silber C. Prevention protocols for Alzheimer disease. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord 1997;:46-9.
Massman PJ, Doody RS. Hemispheric asymmetry in Alzheimer's disease is apparent in motor functioning. J Clin Exp Neuropsychol 1996;18:110-21.
Massman PJ, Kreiter KT, Jankovic J, Doody RS. Neuropsychological functioning in cortical-basal ganglionic degeneration: Differentiation from Alzheimer's disease. Neurology 1996;46:720-6.
Olin JT, Schneider LS, Doody RS, Clark CM, Ferris SH, Morris JC, Reisberg B, Schmitt FA. Clinical evaluation of global change in Alzheimer's disease: identifying consensus. J Geriatr Psychiatry Neurol 1996;9:176-80.
Doody RS, Massman P, Mahurin R, Law S. Positive and negative neuropsychiatric features in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 1995;7:54-60.
Kotrla KJ, Chacko RC, Harper RG, Doody R. Clinical variables associated with psychosis in Alzheimer's disease. Am J Psychiatry 1995;152:1377-9.
Kotrla KJ, Chacko RC, Harper RG, Jhingran S, Doody R. SPECT findings on psychosis in Alzheimer's disease. Am J Psychiatry 1995;152:1470-5.
Doody RS. A reappraisal of localization theory with reference to aphasia. Part 1: Historical considerations. Brain Lang 1993;44:296-326.
Doody RS. A reappraisal of localization theory with reference to aphasia. Part 2: Language theories from outside neurology. Brain Lang 1993;44:327-48.
Doody RS, Jankovic J. The alien hand and related signs. J Neurol Neurosurg Psychiatry 1992;55:806-10.
Feher EP, Mahurin RK, Doody RS, Cooke N, Sims J, Pirozzolo FJ. Establishing the limits of the Mini-Mental State. Examination of 'subtests'. Arch Neurol 1992;49:87-92.
Feher EP, Doody RS, Whitehead J, Pirozzolo FJ. Progressive nonfluent aphasia with dementia: a case report. J Geriatr Psychiatry Neurol 1991;4:236-40.
Doody RS, Rosenfield DB. Spasmodic dysphonia associated with palatal myoclonus. Ear Nose Throat J 1990;69:829-32.
Feher EP, Doody R, Pirozzolo FJ, Appel SH. Mental status assessment of insight and judgment. Clin Geriatr Med 1989;5:477-98.
Ornish D, Scherwitz LW, Doody RS, Kesten D, McLanahan SM, Brown SE, DePuey E, Sonnemaker R, Haynes C, Lester J, McAllister GK, Hall RJ, Burdine JA, Gotto AM, Jr.. Effects of stress management training and dietary changes in treating ischemic heart disease. Jama 1983;249:54-9.
Doody RS, Grose NP. The family medical history: assessing patient understanding of diabetes mellitus. Diabetes Care 1981;4:285-8.

Poster Presentations

Pavlik VN, Doody RS, Rountree SD, Darby EJ. Vitamin E Use is Associated with Improved Survival in an AD Cohort. American Academy of Neurology (AAN), 60th Annual Meeting in Chicago, Illinois (April 12-19, 2008).
Rountree SD, Waring SC, Chan W, Darby EJ, Doody RS. Clinically Presenting Mild Cognitive Impairment (MCI): Variable Presentations and Their Outcomes. International Conference on Alzheimer's Disease and Related Disorders, 10th Annual Meeting in Madrid, Spain (July 15-20, 2006).
Park KW, Pavlik VN, Rountree SD, Darby EJ, Doody RS. Is Functional Decline Necessary for a Diagnosis of Alzheimer's Disease?. International Conference on Alzheimer's Disease and Related Disorders, 10th Annual Meeting in Madrid, Spain (July 15-20, 2006).
Doody RS, Gavrilova S, Aisen P, Hirmand M, Sano M. Dimebon Improves Patient Function and Decreases Caregiver Assistance Time in Alzheimer's Disease: One-Year Clinical Trial Results. American Academy of Neurology (AAN), 60th Annual Meeting in Chicago, Illinois (April 12-19, 2008).
Doody RS, Ferris S, Salloway S, Meuser T, Murthy A, Li MC, Goldman R. Inter-Rater Reliability between Expert and Nonexpert Physicians in the Diagnosis of Amnestic MCI in the Community Setting. American Academy of Neurology (AAN), 60th Annual Meeting in Chicago, Illinois (April 12-19, 2008).
Waring SC, Paranilam JM, Doody RS, Darby EJ, Massman PJ, Chan W. Preprogression Rate, Cardiovascular Comorbidity, and Survival in Alzheimer's Disease. International Conference on Alzheimer's Disease and Related Disorders, 10th Annual Meeting in Madrid, Spain (July 15-20, 2006).
Rountree SD, Chan W, Pavlik VN, Darby EJ, Siddiqui S, Gulley A, Doody RS. Exposure to Anti-dementia Drugs Slows Clinical Progression of Alzheimer's Disease (AD). American Neurological Association (ANA), 132nd Annual Meeting in Washington, DC (Oct. 7-10, 2007).
Rountree SD, Pavlik VN, Chan W, Darby EJ, Doody RS. Clinical Factors Associated with the Preprogression Rate (PPR) in Alzheimer disease (AD). Alzheimer's Association International Conference on Prevention of Dementia, Washington, DC (June 9-12, 2007).

Invited Speaker and Participant in Courses, Workshops, Symposia and Conferences

Key note speaker: Update on Alzheimer's Disease. Annual ADMDC/Alzheimer's Association Houston and SE Texas Chapter Community Program, Houston Museum of Natural Science/IMAX Theater, Houston, Texas. (Aug. 28, 2008)
Symposium chair: Alzheimer's Disease Therapeutics. International Conference on Alzheimer's Disease, Chicago, Ill. (July 30, 2008)
Invited speaker: Cholinesterase Inhibitors and Memantine: What are the Best Practices. Alzheimer's Disease Summit, Washington DC. (May 3, 2008)
Panelist: Research and Exploration. Rice Alumni Leaders, Rice University, Houston, Texas. (April 26, 2008)
LEADe Steering Committee: Late Breaking News Report: Lipitor's Effect in Alzheimer's Disease. American Academy of Neurology, Chicago, Ill. (April 16, 2008)
Invited speaker: Treatment in Alzheimer's Disease. Texas Public Health Association Conference, San Antonio, Texas. (March 7, 2008)
Chair: Clinical Relevance and Treatment Update in Mild Cognitive Impairment. International Hong Kong/Springfield Pan-Asia Symposium on Advances in Alzheimer's Disease Therapy. (Feb. 29, 2008)
Invited speaker: Latest Update on Alzheimer's Disease. Singapore General Hospital/Tan Tock Seng Hospital, Singapore. (Feb. 26, 2008)
Invited speaker: Progression of Alzheimer's Disease. Baylor Neurology Grand Rounds, Houston, Texas. (Feb. 22, 2008)
Invited speaker: Alzheimer's Disease Therapeutics. Schering-Plough, Kenilworth, N.J. (Feb. 8, 2008)
Invited speaker: Aspects of Memory. Sciencia Society, Rice University, Houston, Texas. (Jan. 15, 2008)
Invited speaker: Update on Alzheimer's Disease. ADMDC/Alzheimer's Association Annual Community Update, Houston, Texas. (Sept. 6, 2007)
Invited speaker: The Development of Alzheimer's Disease Therapies from the Laboratory to Practice. 2007 Texas Conference on Alzheimer's Disease and Care, Austin, Texas. (Aug. 23, 2007)
Co-Chair: Emerging Compounds. Alzheimer's Association International Conference on Prevention of Alzheimer's Disease, Washington, DC. (June 12, 2007)
Invited speaker: Update on Alzheimer's Disease. Baylor College of Medicine Neurology Grand Rounds, Houston, Texas. (Jan. 29, 2007)
Invited speaker: What is Really Known about Prevention and Treatment of Alzheimer's Disease. ADMDC/Alzheimer's Association Annual Community Update, Houston, Texas. (Aug. 31, 2006)
Co-Chair: 10th International Conference on Alzheimer's Disease and Related Disorders, Madrid, Spain. (July 19, 2006)
Co-Chair: Neurologic Highlights: Dementia and Behavioral Neurology. American Academy of Neurology, San Diego, Calif. (April 6, 2006)
Invited speaker: Treating Alzheimer's Disease from a Specialist's Perspective. Central Texas Health Care System, Waco, Texas. (March 9, 2006)
Invited speaker: Alzheimer's Disease and Mild Cognitive Impairment. Texas Neurological Society, Austin, Texas. (Feb. 24, 2006)
Invited speaker: Update on Alzheimer's Disease. ADMDC/Alzheimer's Association Annual Community Update, Houston, Texas. (Sept. 19, 2005)
Co-Chair: Dementia and Aging. American Academy of Neurology, Miami, Fla. (April 13, 2005)
Invited speaker: Prevention and Treatment of Alzheimer's Disease. Baylor Methodist Neurology Grand Rounds, Houston, Texas. (March 21, 2005)
Invited speaker: Prevention and Treatment of Alzheimer's Disease. American Association of Clinical Psychiatrists, Houston, Texas. (March 18, 2005)
Invited speaker: Prevention and Treatment of Alzheimer's Disease. Texas Neurological Society, Austin, Texas. (Feb. 11, 2005)

Contact Information

Rachelle S. Doody, M.D., Ph.D.
Department of Neurology
Baylor College of Medicine
One Baylor Plaza, MS NB302
Houston, Texas 77030

Tel: 713-798-7416
Fax: 713-798-5326
Email: